ResearcherPenn State Cancer InstituteNo recent work listed

Chandra Prakash Belani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5049-5329; OpenAlex author ID A5015680000. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2014: 1 paper

Papers 1

Phase I dose escalation study of capecitabine and erlotinib concurrent with radiation in locally advanced pancreatic cancer. Last author DOI 10.1007/s00280-014-2488-7 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yixing Jiang · 1 shared paper, 2014 · strength 0.04
- Paper Phase I dose escalation study of capecitabine and erlotinib concurrent with radiation in locally advanced pancreatic ca… DOI 10.1007/s00280-014-2488-7 ↗
Eric T. Kimchi · 1 shared paper, 2014 · strength 0.04
- Paper Phase I dose escalation study of capecitabine and erlotinib concurrent with radiation in locally advanced pancreatic ca… DOI 10.1007/s00280-014-2488-7 ↗
Niraj Jaysukh Gusani · 1 shared paper, 2014 · strength 0.04
- Paper Phase I dose escalation study of capecitabine and erlotinib concurrent with radiation in locally advanced pancreatic ca… DOI 10.1007/s00280-014-2488-7 ↗
Jussuf T. Kaifi · 1 shared paper, 2014 · strength 0.04
- Paper Phase I dose escalation study of capecitabine and erlotinib concurrent with radiation in locally advanced pancreatic ca… DOI 10.1007/s00280-014-2488-7 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.